hostile takeover
Carl Icahn Plans to Acquire Stake in Hologic; Company Responds with Poison Pill
NEW YORK (GenomeWeb News) – Following notification by a hedge fund headed by Carl Icahn of its intentions to acquire a stake in Hologic, the Bedford, Mass.-based firm today announced it has adopted a stockholder rights plan "intended to ensure that the board remains in the best position to perfor
Roche Won't Extend Offer for Illumina as Shareholders Re-elect Flatley, Others to Board
This article has been updated with comments from an internal Illumina e-mail.
Amid Chase for Illumina, Roche Posts Q1 MDx Sales Jump as Applied Science Drops
NEW YORK (GenomeWeb News) – Roche today reported that its molecular diagnostics sales increased 4 percent year over year, while its sales for microarrays and genomic sequencing products dropped sharply.
Apr 2, 2012
Illumina Rejects Roche's Latest Offer
Mar 29, 2012
Roche Raises Bid to Acquire Illumina to $6.7B
Mar 9, 2012
Illumina Sued Again Over Roche Bid
Jan 31, 2012